Gentag believes that wearable biosensors linked with NFC devices have the power to transform medical and consumer diagnostics. We first patented the concept of an electronic “second skin” over a decade ago.
From the National Labs to Hospitals and Homes
Radar Responsive Tags, a sophisticated geolocation and tracking technology, are capable of precision locating items or individuals over large areas. First developed at the US National Laboratories for the Department of Defense, these tiny wireless chips, combined with sensors, are capable of providing exquisite location services.
This is a text block. Click the edit button to change this text.
Working to reduce costly hospital readmissions
By linking patients, wearable biological sensors that can be read with an encrypted NFC device, and doctors or hospitals, Gentag is working to reduce costly hospital readmissions, simplify patient discharge, and enable easy in-home self-monitoring.
- January 12, 2016Read more
Can the IoT Actually Be Secure? These Two Companies Say Yes Gentag and Security First Corp. Sign Agreement to Secure NFC Sensor Transactions WASHINGTON, DC and RANCHO SANTA MARGARITA, CA–(Marketwired – Jan 11, 2016) – Gentag Inc. and Security First Corp. have announced an agreement to secure NFC and sensor transactions for the Internet of Things (IoT). California-based Security First Corp.’s patented cryptographic splitting technology called SPx™ (SecureParser® extended), which uses multi-factor secret sharing, will be used to secure NFC and other IoT sensor solutions for personal identification, contactless payments, healthcare, fitness, and home applications. By leveraging both companies’ expertise, security standards will...
- September 18, 2015Read more
Gentag’s pain-free wearable diabetes patch technology was mentioned in an article that appeared in the September 19th print edition of The Economist. For the full article, please visit: http://www.economist.com/news/science-and-technology/21664942-patches-skin-can-analyse-sweat-and-monitor-glucose-sweating-big-stuff
Gentag, Mayo Clinic, NovioSense and Fraunhofer Join Forces to Lower the Cost of Diabetes Care GloballyJuly 14, 2015Read more
WASHINGTON, ROCHESTER, Minn., NIJMEGEN, Netherlands and DUISBURG, Germany, July 14, 2015 /PRNewswire/ — Exciting, new, patented technology platform poised to disrupt diabetes care delivery globally Extremely low-cost, pain-free system could be a game changer No more lancets, glucometers Real-time cloud-based readings deliverable to caregivers and providers anywhere instantly via NFC cell phones Opportunity to improve diabetes outcomes worldwide Building on the long-standing collaboration between Gentag and Mayo Clinic, and the long-standing collaboration between NovioSense and Fraunhofer Institute for Microelectronic Circuits and Systems (IMS), Gentag and NovioSense today announced that they have formed a joint venture to combat the epidemic of type 2 diabetes that is...